TANG KEVIN purchased $715K of BOLD (indirect holdings)
TANG KEVIN purchased 286,333 indirectly-held shares of Boundless Bio, Inc. (BOLD) at an average of $2.50 ($2.47–$2.56, $0.71M total) across 6 trades over 2026-06-25 to 2026-06-29.
How this was made
The 30-second read
Why it matters
The newest fact is the disclosed open-market purchase by a 10% owner totaling ~$714.8K across six trades, with holdings after the transaction at 2,533,845 shares.
Market read
Traders may treat the filing as a modest sentiment input, but it does not introduce new operational or financial guidance.
What to watch
The purchase price range ($2.47–$2.56) may reflect prevailing liquidity/market conditions; without context on prior holdings or motivations, the signal strength is uncertain.
Background
The article is an SEC Form 4 insider transaction disclosure for Boundless Bio, Inc. (BOLD).
Ticker impact
SEC Form 4 shows 10% owner Tang Kevin bought 286,333 shares of Boundless Bio (BOLD) for ~$714.8K at $2.47–$2.56.
Near-term impact likely limited; any effect is sentiment-driven and may fade unless followed by additional disclosures.
The filing is primary-source and time-stamped (filed 2026-06-29), but it lacks new company fundamentals (no guidance, trial, or deal) and is an indirect holding purchase.
Market effects
Minimal; this is company-specific insider activity with no sector-wide regulatory/clinical signal.
None indicated.
None indicated.
Counterpoint
Insider buying can be routine (tax/portfolio rebalancing) and the indirect nature plus lack of a 10b5-1 plan reduces interpretability.
Key entities
- issuerBoundless Bio, Inc.
Public company subject of the Form 4 insider transaction disclosure.
- insiderTang Kevin
10% owner reporting an open-market purchase via indirect holdings.